Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source

Clin Infect Dis. 2015 Jun 1;60(11):1726-8. doi: 10.1093/cid/civ130. Epub 2015 Feb 19.

¹ Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston University of Houston College of Pharmacy.
² Department of Pharmacy, Baylor St Luke's Medical Center, Houston, Texas.
³ Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
⁴ Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston Universidad El Bosque, Bogotá, Colombia.
⁵ University of Houston College of Pharmacy Department of Microbiology and Molecular Genetics, University of Texas Health Science Center at Houston.

No abstract available

Publication types